Table 1. Correlation of microRNA-126 relative expression in tumor with clinicopathological characteristics of patient with cholangiocarcinoma.

Clinicopathological analysis in hilar cholangiocarcinoma
Variable	miR-126 low	miR-126 high	P
No. of patients	18	27
Gender			0.895
Female	8 (44.4%)	13 (46.4%)
Male	10 (55.6%)	14 (53.6%)
Patient age, years			0.170
≤ 60	10 (55.6%)	20 (75.0%)
> 60	8 (44.4%)	7 (25.0%)
Tumor size			0.0001
≤ 50 mm	8 (44.4%)	27 (100%)
> 50 mm	10 (55.6%)	0 (0%)
Pathologic N stage			0.542
Positive	7 (38.8%)	14 (51.9%)
Negative	11 (61.2%)	13 (48.1%)
Histologic differentiation			0.798
Well	4 (22.2%)	4 (14.8%)
Moderate/poor	13 (77.8%)	23 (85.2%)
Clinicopathological analysis in intrahepatic cholangiocarcinoma
Variable	miR-126 low	miR-126 high	p
No. of patients	29	14
Gender			0.676
Female	15 (55.6%)	8 (57.1%)
Male	14 (44.4%)	6 (42.9%)
Patient age, years			0.524
≤ 60	12 (41.4%)	4 (28.6%)
> 60	17 (58.6%)	10 (71.4%)
Tumor size			0.967
≤ 50 mm	9 (31.0%)	4 (28.6%)
> 50 mm	20 (69.0%)	10 (71.4%)
Pathologic N stage			0.013
Positive	14 (47.4%)	1 (7.1%)
Negative	15 (52.6%)	13 (92.9%)
Histologic differentiation			0.529
Well	20 (69.0%)	9 (64.3%)
Moderate/poor	9 (31.0%)	5 (35.7%)